PAP Devices Market to Be Worth $6.97 Billion by 2031 – Exclusive Report by Meticulous Research®

PAP Devices Market to Be Worth .97 Billion by 2031 – Exclusive Report by Meticulous Research®

REDDING, Calif., July 10, 2024 /PRNewswire/ — According to a new market research report titled, PAP Devices Market Size, Share, Forecast, & Trends Analysis by Type (CPAP, BiPAP, APAP, Accessories (Masks, Headgear)), Disease (Obstructive Sleep Apnea, COPD, Respiratory Failure) End User (Hospitals, Home Healthcare Settings) – Global Forecast to 2031,’ published by Meticulous Research®The PAP devices market is planned to reach $6.97 billion by 2031, at a CAGR of 5.2% from 2024 to 2031.

Download Sample Report Now-

Positive airway pressure (PAP) devices pump air under pressure into the airway of the lungs. These devices prevent airways from collapsing, which may slow down breathing in people with respiratory problems such as obstructive sleep apnea. (OSA). Positive airway pressure (PAP) devices are used in hospitals, sleep clinics, and home healthcare settings to treat adult and pediatric or neonatal patients. Types of PAP devices include continuous positive airway pressure (CPAP) devices, bilevel positive airway pressure (BiPAP) devices, and automatic positive airway pressure (APAP) devices.

The growth of this market is driven by the increasing prevalence of respiratory and sleeping disorders, the rising geriatric population suffering from respiratory disorders, the introduction of new sleep apnea devices, growing awareness about the adverse effects of untreated sleep apnea, and favorable reimbursement policies for sleep apnea therapies and devices. However, PAP devices are expensive and not suitable for patients with certain conditions, which restrains the market’s growth.

Furthermore, technological advances in Positive Airway Pressure (PAP) devices and a rising preference for out-of-hospital healthcare are expected to offer significant market growth opportunities. However, the side effects of PAP devices and the low adherence rate for sleep apnea devices are challenging the market’s growth.

Get a Glimpse Inside: Request Sample Pages-

Product Launches and Approvals to Boost the Growth of the PAP Devices Market

A positive airway pressure (PAP) device helps sleep apnea patients by blowing pressurized air through the airway to keep the throat open. According to the National Institutes of Health (NIH), in 2020, 26% of people in the US aged 30–70 years were affected by sleep apnea.

PAP devices keep patients’ airways open while sleeping, allowing them to breathe the oxygen they require for optimal functioning. Therefore, various PAP devices are adopted to induce better sleep and treat other sleep-related conditions. Key players are focused on product launches and approvals to strengthen their positions in the market. For instance:

  • Of March 2023Inspire Medical Systems, Inc. (US) received approval from the US Food and Drug Administration (FDA) for its Inspire therapy for pediatric patients with obstructive sleep apnea.
  • Of August 2021ResMed Inc. (US) launched the AirSense 11 PAP Series devices to improve the treatment and management of sleep apnea.

Such developments are expected to drive the growth of this market.

The PAP devices market is segmented based on Product (Continuous Positive Airway Pressure (CPAP) Devices, Bilevel Positive Airway Pressure (BiPAP) Devices, Automatic Positive Airway Pressure (APAP) Devices, Accessories (Masks {Full Face Masks, Nasal Masks, Nasal Pillows /Cushion Masks}, Headgear, Other Accessories)), Application (Obstructive Sleep Apnea (OSA), Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Heart Failure), End User (Hospitals and Sleep Clinics, Home Healthcare Settings), and Geography. The study also evaluates industry competitors and analyzes the market at the regional and country levels.

Have Specific Research Needs? Request a Customized Report-

The report also includes an extensive assessment of the key growth strategies adopted by leading market players in the last three to four years. Some of the key players operating in the PAP devices market are ResMed Inc. (US), Koninklijke Philips NV (Netherlands), Inspire Medical Systems, Inc. (US), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Medtronic plc (Ireland), Rotech Healthcare Inc. (US), Cardinal Health, Inc. (US), Invacare Corporation (US), Cleveland Medical Devices Inc. (US), BMC Medical Co., Ltd. (China), Lowenstein Medical Technology GmbH + Co. KG. (Germany), SomnoMed, Inc. (Australia), Drive DeVilbiss Healthcare Ltd. (US), and SunMed, LLC (US).

Based on product, by 2024, the CPAP devices segment is expected to account for the largest share of 68.2% of the PAP devices market. The high adoption of CPAP devices for the first-line treatment of sleep disorders due to their benefits, such as non-invasiveness, high effectiveness, increased mental alertness and better mood, faster control of sleep disorders, and improved sleep quality, support the segment’s large market share.

Based on disease, in 2024, the obstructive sleep apnea (OSA) segment is expected to account for the largest share of the PAP devices market. Initiatives supporting the early diagnosis, screening, and treatment of obstructive sleep apnea and increasing awareness about the treatment and adverse effects of obstructive sleep apnea contribute to the segment’s large market share.

Based on end user, in 2024, the hospitals and sleep clinics segment is expected to account for the largest share of 69.9% of the PAP devices market. PAP devices improve sleep quality, minimize morning headaches and sleep interruptions, and help reduce snoring. Hence, hospitals and sleep clinics prefer advanced PAP devices over other devices. Additionally, the increasing prevalence of co-morbidities such as obesity and cardiovascular disorders, the rising number of undiagnosed sleep apnea patients, and the large pool of patients with sleep apnea syndrome visiting hospitals & sleep clinics for diagnosis support the segment’s large market share.

Based on geography, the PAP devices market is segmented into North America (BASE, Canada), Europe (Germany, FranceUK, Italy, Spain, Switzerland, Netherlands, Sweden, Belgium, Denmarkand the Rest of Europe), Asia Pacific (Japan, China, India, South Korea, Australiaand the Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentinaand the Rest of Latin America), and the Middle East & Africa (Saudi ArabiaUAE, South AfricaRest of Middle East & Africa). In 2024, North America is expected to account for the largest share of 41.5% of the PAP devices market. North America’s The large market share can be attributed to the increasing demand for PAP devices and the higher adoption of advanced medical devices in the region. Moreover, the increasing number of organic and inorganic developments by key players, such as product launches, product approvals, and acquisitions, is expected to contribute to the growth of this regional market.

Browse In-depth Report Now-

Scope of the Report:

PAP Devices Market Size & Trends Analysis—by Product

  • Continuous Positive Airway Pressure (CPAP) Devices
  • Bilevel Positive Airway Pressure (BiPAP) Devices
  • Automatic Positive Airway Pressure (APAP) Devices
  • Accessories
    • Masks
      • Full Face Masks
      • Nasal Masks
      • Nasal Pillows/Cushion Masks
    • Headgear
    • Other Accessories
      Note: Other accessories include air filters, CPAP pillow, nasal pads, and power adapters & batteries.

PAP Devices Market Size & Trends Analysis—by Disease

  • Obstructive Sleep Apnea (OSA)
  • Respiratory Failure
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Heart Failure

PAP Devices Market Size & Trends Analysis—by End User

  • Hospitals and Sleep Clinics
  • Home Healthcare Settings

PAP Devices Market Size & Trends Analysis—by Geography

  • North America
  • Europe
    • Germany
    • France
    • Italy
    • UK
    • Spain
    • Switzerland
    • Netherlands
    • Sweden
    • Belgium
    • Denmark
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East & Africa

Unlock Opportunities: Buy Now-

Related Reports:

Digital Therapeutics Market by Component (Software, Device), Application (Diabetes, Respiratory, CNS, Gastrointestinal, Cardiovascular, Addiction, Rehabilitation, Obesity, Nutrition), End User (Patient, Payer, Provider, Employer)—Global Forecast to 2030

Home Healthcare Market by Offering (Fertility, Pregnancy, Cholesterol Tests, Oximeters, CPAP, Nebulizers, Ventilators, Dialysis, Patient Support Equipment), Service (Rehabilitation, Telehealth, Nursing, Hospice), Application (Cardiovascular, Diabetes, Respiratory)—Global Forecast to 2030

Latin America Home Healthcare Market by Offering (Equipment (Therapeutic {Insulin, Dialysis}, Diagnostics {Blood Pressure, Heart Rate}, Mobility), Service (Skilled {Primary Care, Nursing, Nutritional}), Application (CVD, Diabetes, Cancer)—Forecast to 2030

Ventilators Market by Product (Instruments, Accessories), Mobility (Intensive Care, Portable), Interface (Invasive, Non-invasive), Age Group (Adult, Pediatric), Mode (Volume, Pressure, Dual), End User (Hospitals, ASCs, Home Care)—Global Forecast to 2027

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia Pacific, Latin Americaand the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present critical market data with great attention to detail. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California96001, US
USA: +1-646-781-8004
Europe: +44-203-868-8738
APAC: +91 744-7780008
Email- [email protected]
Visit Our Website:
Connect with us on LinkedIn-
Content Source: